Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

[Advances in application of cell imprinting technology in biomedical field]

Zhao XM., Zhang ZY., Sun WJ., Qing GY.

Narrative Review on Face & Skin, published in Se Pu (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Se Pu (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41530088
PMCID
PMC12801125
DOI
10.3724/sp.j.1123.2025.04007
Citations
1

Abstract (original English)

Cell imprinting technology, as a key technique in the field of cell-specific recognition, has become an important cornerstone of modern biomedical research. It relies on its precise recognition capability for biomarkers such as cell surface antigens and receptors. This technology is not only widely applied in basic fields, including disease marker detection and research on cell function and behavioral mechanisms, but also plays a crucial role in frontier applications like rare cell isolation and targeted drug development. It continuously promotes the innovative development of life science research. Although significant progress has been made in this technology, it still faces several urgent challenges. These specifically include optimization of the imprinting process (to enhance anti-interference ability and fidelity) and development of new methods adapted to complex biological environments. In response to these issues, researchers have achieved breakthrough progress in multiple fields through innovative material design and process optimization recently. First, in rare cell capture, this technology has significantly improved the separation efficiency of key rare cells in complex samples, providing an efficient solution for early cancer diagnosis and blood disease research. Second, in the field of cell culture, its unique imprinted surface can precisely regulate the expression o

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansCell Culture TechniquesCell SeparationBiosensing TechniquesMolecular Imprinting

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research